JP2024529088A5 - - Google Patents

Info

Publication number
JP2024529088A5
JP2024529088A5 JP2024508024A JP2024508024A JP2024529088A5 JP 2024529088 A5 JP2024529088 A5 JP 2024529088A5 JP 2024508024 A JP2024508024 A JP 2024508024A JP 2024508024 A JP2024508024 A JP 2024508024A JP 2024529088 A5 JP2024529088 A5 JP 2024529088A5
Authority
JP
Japan
Prior art keywords
optionally substituted
benzo
dihydro
urea
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529088A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/057490 external-priority patent/WO2023017451A1/en
Publication of JP2024529088A publication Critical patent/JP2024529088A/ja
Publication of JP2024529088A5 publication Critical patent/JP2024529088A5/ja
Pending legal-status Critical Current

Links

JP2024508024A 2021-08-11 2022-08-11 小分子stingアンタゴニスト Pending JP2024529088A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB202111556 2021-08-11
GB2111556.3 2021-08-11
IN202111036317 2021-08-11
IN202111036317 2021-08-11
PCT/IB2022/057490 WO2023017451A1 (en) 2021-08-11 2022-08-11 Small molecule sting antagonists

Publications (2)

Publication Number Publication Date
JP2024529088A JP2024529088A (ja) 2024-08-01
JP2024529088A5 true JP2024529088A5 (enExample) 2025-07-07

Family

ID=83355624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508024A Pending JP2024529088A (ja) 2021-08-11 2022-08-11 小分子stingアンタゴニスト

Country Status (8)

Country Link
EP (1) EP4384267A1 (enExample)
JP (1) JP2024529088A (enExample)
KR (1) KR20240046742A (enExample)
AU (1) AU2022325543A1 (enExample)
CA (1) CA3228528A1 (enExample)
IL (1) IL310705A (enExample)
TW (1) TW202321232A (enExample)
WO (1) WO2023017451A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025016379A1 (zh) * 2023-07-19 2025-01-23 中国科学院上海药物研究所 氮杂环丁烷类化合物及其医药用途
CN120794957A (zh) * 2024-05-14 2025-10-17 中国药科大学 苯并含氮杂环类sting抑制剂及其医药用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
CN102516153B (zh) * 2011-12-14 2014-03-12 南京工业大学 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用
US8969325B2 (en) * 2011-12-19 2015-03-03 Abbvie Inc. TRPV1 antagonists
US20200138827A1 (en) * 2017-06-22 2020-05-07 Curadev Pharma Limited Small molecule modulators of human sting
UA125730C2 (uk) 2017-06-22 2022-05-25 Курадев Фарма Лімітед Низькомолекулярні модулятори sting людини
WO2019243823A1 (en) * 2018-06-21 2019-12-26 Curadev Pharma Limited Azaheterocyclic small molecule modulators of human sting
CN120004785A (zh) * 2018-07-03 2025-05-16 诺华制药股份有限公司 用于治疗与sting活性有关的疾病的化合物和组合物
UY38905A (es) * 2019-10-03 2021-04-30 Ifm Due Inc Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting
CA3166358A1 (en) * 2020-02-12 2021-08-19 Monali BANERJEE Small molecule sting antagonists

Similar Documents

Publication Publication Date Title
JP2023513241A5 (enExample)
EP2712616B1 (en) Intermediates for the preparation of 1-(acetyl)-piperidine and 1-(acetyl)-piperazine derivatives as fungicides for use in plant protection
JP5412429B2 (ja) 抗細菌性アミド及びスルホンアミド置換複素環式尿素化合物
ME02906B (me) Derivati pirazolopirolidina i njihova upotreba u liječenju bolesti
JP2024529088A5 (enExample)
JP2010501180A5 (enExample)
JP2019504009A5 (enExample)
HRP20150082T1 (hr) Derivati pirazolo piridina kao inhibitori nadph oksidaze
JP2019537594A5 (enExample)
JP2007519694A5 (enExample)
CA2483159A1 (en) Triazole derivatives as tachykinin receptor antagonists
RU2018123779A (ru) Новые соединения
HRP20191821T1 (hr) Antiproliferativni spojevi i načini njihove uporabe
RU2019135155A (ru) Фунгицидные оксадиазолы
RU2009133794A (ru) Гербициды на основе замещенного n-оксида пиридина
RU2008141511A (ru) Конденсированные гетероциклические соединения и их применение в качестве модуляторов mglur5
CA2602248A1 (en) Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
JP2020516671A5 (enExample)
HRP20150347T1 (hr) Analozi 2-aminopiridina kao aktivatori glukokinaze
JP2005525324A5 (enExample)
RU2005117383A (ru) Производные фенилаланина в качестве ингибиторов дипептидилпептидазы для лечения или профилактики диабета
HRP20200962T1 (hr) Novi spojevi
JP2004518651A5 (enExample)
IL283539B1 (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
JP2012506848A5 (enExample)